Celebrating Nitika Pharma’s India Pharma Awards 2025 Winner of Excellence in Quality
We are delighted to share that Nitika Pharmaceutical Specialities Pvt. Ltd. has been honoured at the India Pharma Awards 2025 in the category:
🏆 Excellence in Quality – Nitrosamine Risk Mitigation through Novel Low-Nitrite Excipients
This recognition is a proud milestone in our journey to make medicines safer and more reliable for patients across the globe.
Over the past few years, nitrosamine control has become a key focus area for regulators and pharmaceutical companies worldwide. At Nitika, we took this challenge as an opportunity to innovate and redesign our processes to develop novel low-nitrite excipients that help our customers reduce nitrosamine risk in their formulations.
This recognition is a testament to:
Our R&D and quality teams who worked deeply on nitrite control and robust analytics.
Our manufacturing and operations teams who translated ideas into consistent, scalable processes, and
Our customers and partners, who trusted us and collaborated with us on their nitrosamine mitigation strategies.
For us, this award is not just about a single product or project—it reflects our broader commitment to patient safety, regulatory readiness, and quality-by-design at the excipient level.
